- $343.04bn
- $400.56bn
- $54.32bn
- 80
- 30
- 93
- 75
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 33,266 | 45,804 | 56,197 | 58,054 | 54,318 |
Cost of Revenue | |||||
Gross Profit | 25,660 | 30,547 | 38,883 | 41,527 | 36,092 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 20,283 | 34,441 | 38,273 | 39,937 | 41,561 |
Operating Profit | 12,983 | 11,363 | 17,924 | 18,117 | 12,757 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 8,426 | 3,398 | 12,989 | 13,477 | 6,250 |
Provision for Income Taxes | |||||
Net Income After Taxes | 7,882 | 4,622 | 11,549 | 11,845 | 4,873 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 7,882 | 4,616 | 11,542 | 11,836 | 4,863 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 7,842 | 4,556 | 11,468 | 11,782 | 4,820 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.97 | 3.9 | 7.32 | 7.78 | 4.54 |
Dividends per Share |